Glucosteril Baxter (Glucose)

Glucosteril Baxter is indicated for several clinical situations where rapid glucose delivery or fluid replacement is required. It is commonly employed in the following contexts:

• Treatment of hypoglycemia in patients unable to take oral glucose
• Component of parenteral nutrition regimens for patients lacking enteral intake
• Fluid and electrolyte replacement during surgery or critical illness
• Support for metabolic needs during prolonged fasting or catabolic states
• Adjunctive therapy in certain metabolic disorders under specialist supervision

Side effects of intravenous glucose solutions are generally related to the infusion rate, concentration, and patient-specific factors.

Common

• Hyperglycemia due to excessive glucose administration
• Local irritation or phlebitis at the infusion site
• Electrolyte imbalances, particularly hyponatremia or hyperkalemia
• Fluid overload leading to peripheral edema
• Mild nausea or abdominal discomfort

Serious

• Severe hyperglycemia with risk of ketoacidosis
• Allergic reaction or anaphylaxis (rare)
• Severe electrolyte disturbances causing cardiac arrhythmias
• Pulmonary edema in patients with compromised cardiac function
• Intravascular infection if aseptic technique is breached

When using Glucosteril Baxter, clinicians should consider several safety measures to minimize risks. Important precautions include:

• Assess baseline blood glucose and monitor levels frequently during infusion
• Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload
• Use caution in neonates, infants, and elderly patients due to altered glucose metabolism
• Verify compatibility with other intravenous solutions before co-administration
• Ensure proper aseptic technique to prevent catheter-related infections
• Review patient history for known hypersensitivity to glucose solutions

Glucose solutions can interact with other medications or clinical conditions, influencing therapeutic outcomes.

Avoid

• Co-administration with high-dose insulin without close glucose monitoring
• Simultaneous infusion of potassium-containing solutions without electrolyte assessment
• Use in patients with severe hyperglycemia uncontrolled by insulin therapy

Use with caution

• Concurrent use of diuretics that may affect fluid balance
• Administration alongside corticosteroids that raise blood glucose levels
• Patients receiving total parenteral nutrition containing other carbohydrate sources
• Situations where rapid shifts in osmolarity could precipitate cerebral edema